Corvel Corp (CRVL) Stock Price & Analysis
Corvel Corp (CRVL) rose 2.05% to USD 61.11 as of June 10, 2026 at 01:08 UTC, according to Nexqual real-time market data.
CRVL last closed at USD 59.88; the session ranged USD 59.61–61.48 on volume of 171,100 shares. Market capitalization is $3.10B, with a 52-week range of USD 44.83–109.95 (NMS). Source: Nexqual, June 10, 2026 at 01:08 UTC.
Key Statistics (as of June 10, 2026 at 01:08 UTC)
| Price | USD 61.11 |
|---|---|
| Change | ▲ 2.05% (up) |
| Previous Close | USD 59.88 |
| Open | USD 59.95 |
| Day Range | USD 59.61 – 61.48 |
| 52-Week Range | USD 44.83 – 109.95 |
| Volume | 171,100 shares |
| Market Cap | $3.10B |
| Exchange | NMS |
Technical Analysis (CRVL)
Nexqual's technical model rates CRVL "STRONG BUY" based on 5 bullish and 0 bearish signals across 124 daily candles, as of June 10, 2026 at 01:08 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 55.12 (neutral) |
| vs SMA50 | Above (USD 57.55) |
| MACD | 0.69 (positive) |
Analyst Ratings (CRVL)
Wall Street analysts rate CRVL "None", per Nexqual as of June 10, 2026 at 01:08 UTC.
| Consensus Rating | None |
|---|
Earnings (CRVL)
| Next Earnings Date | 2026-08-04 |
|---|
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2014-12-31 | USD 0.11 vs est 0.14 ▼ miss |
| 2014-09-30 | USD 0.12 vs est 0.16 ▼ miss |
| 2014-06-30 | USD 0.13 vs est 0.16 ▼ miss |
| 2014-03-31 | USD 0.13 vs est 0.14 ▼ miss |
Source: Nexqual, June 10, 2026 at 01:08 UTC.
Financials & Fundamentals (CRVL)
| Total Revenue | $958.53M |
|---|---|
| Revenue Growth (YoY) | +7.40% |
| Gross Margin | +24.29% |
| Operating Margin | +15.98% |
| Profit Margin | +11.51% |
| ROE | +30.81% |
| Debt / Equity | 7.13 |
| Current Ratio | 2.03 |
| Total Cash | $233.07M |
| Total Debt | $28.11M |
| Free Cash Flow | $92.89M |
Source: Nexqual, June 10, 2026 at 01:08 UTC.
Financial Health Score (CRVL)
Nexqual rates Corvel Corp's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 01:08 UTC.
| Growth | Solid — Revenue +12% YoY (annual) |
|---|---|
| Profitability | Mixed — Gross margin 24%, operating 16% |
| Balance Sheet | Strong — $233M cash vs $28M debt, net cash position |
| Cash Flow | Strong — FCF $93M, 19% margin |
| Efficiency | Strong — ROE 31%, ROA 15.0% |
Ownership (CRVL)
| Insider Ownership | +44.10% |
|---|---|
| Institutional Ownership | +55.39% |
| Shares Outstanding | 50.69M |
| Float | 28.30M |
| Short % of Float | +5.06% |
Source: Nexqual, June 10, 2026 at 01:08 UTC.
Leadership (CRVL)
Corvel Corp is led by Michael G. Combs (age 61), President, CEO & Chairman, per Nexqual as of June 10, 2026 at 01:08 UTC.
| President, CEO & Chairman | Michael G. Combs (age 61) |
|---|---|
| Vice President of Accounting | Jennifer L. Yoss (age 47) |
| Executive Vice President of Risk Management Services | Mark E. Bertels (age 61) |
| Chief Financial Officer | Brian Nichols (age 45) |
| Vice President of Legal Services | Sharon F. O'Connor |
Major Backers & Investors (CRVL)
Notable institutional backers of Corvel Corp include Kayne Anderson Rudnick Investment Management LLC, Renaissance Technologies, Virtus Equity Trust-Virtus KAR Small-Cap Core Fund, according to Nexqual as of June 10, 2026 at 01:08 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Kayne Anderson Rudnick Investment Management LLC | 9.61% |
| Renaissance Technologies | 3.19% |
| Virtus Equity Trust-Virtus KAR Small-Cap Core Fund | 1.74% |
| Morgan Stanley | 1.37% |
| Wells Fargo & Company | 0.91% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 14.72% |
| Vanguard Group | 10.35% |
| State Street | 2.95% |
| Dimensional Fund Advisors | 2.29% |
| Geode Capital | 1.85% |
Source: Nexqual, June 10, 2026 at 01:08 UTC.
From Corvel Corp's Latest SEC 10-K Filing (filed 2026-05-22)
Key Strengths & Strategy (as disclosed to the SEC)
- CorVel Corporation provides workers' compensation, general and auto liability, and hospital bill auditing and payment integrity solutions.
- It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs.
- The company also offers network solutions services, including automated medical fee auditing; preferred provider management and reimbursement; retrospective utilization, facility claim, and professional review; pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.
- In addition, it provides a range of patient management services, such as claims management customers, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CHCO | City Holding Company | USD 128.18 | ▲ 1.1% |
| CVCO | Cavco Industries, Inc. | USD 578.31 | ▲ 5.16% |
| DORM | Dorman Products, Inc. | USD 127.98 | ▲ 0.75% |
| EXPO | Exponent, Inc. | USD 57.23 | ▼ 4.07% |
| CRAI | CRA International,Inc. | USD 148.44 | ▲ 1.87% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 01:08 UTC. This page is informational and not investment advice.